Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-5,580,998 |
Process for preparing taxoids The invention relates to a process for preparing taxoids of formula I herein that includes comprising the steps of esterifying a baccatin III derivative of the... |
| US-5,580,997 |
Baccatin III derivatives New Baccatin III derivatives are disclosed for use in making taxoid compounds having formula (I) illustrated herein that exhibit antitumor activity. |
| US-5,580,996 |
Oxygen-containing aliphatic compounds and their use as intermediates for
the preparation of 4-hydroxy-2,... The compounds of the invention are characterised by the formulae ##STR1## wherein index p represents an integer equal to 2 or 3 and q can take the value... |
| US-5,580,995 |
Process for preparing anhydride-functional monomers Anhydride-functional polymerizable monomers having the structure: ##STR1## and polymers and reactive compositions prepared from these monomers are ... |
| US-5,580,994 |
Preparation of tetrahydropyran-4-carboxylic acid and its esters A process for preparing tetrahydropyran-4-carboxylic acid and its esters of the formula I ##STR1## (R=H, C.sub.1 -C.sub.8 -alkyl, C.sub.3 -C.sub.8... |
| US-5,580,993 |
Process for the preparation of iopamidol and
5-amino-2,2-dialkyl-1,3-dioxanes A process for the preparation of Iopamidol and 5-amino-2,2-dialkyl-1,3-dioxanes of formula ##STR1## wherein R and R.sub.1 are the same or different and... |
| US-5,580,992 |
Olefinic monomers containing pendant perfluorinated cyclic ether moieties A fluorine-containing compound represented by the following general formula (1): ##STR1## wherein A represents a group --CH.sub.2 --CH.dbd.CH.sub.2 or a... |
| US-5,580,991 |
Process for preparing butyrolactone and method for separating organic
phosphorous-ruthenium complex as catalyst... The disclosure describes a method for separating a ruthenium complex, which comprises removing an objective hydrogenation reaction product from a hydrogenation... |
| US-5,580,990 |
Pt-containing compound, process for its preparation, and application of
such compounds Pt-containing compound with the formula {Pt.sup.II (w)(x)(y)(z)} or {Pt.sup.IV (u)(v)(w)(x)(y)(z)}, wherein u, v, w, x, y and z represent whether or not the same... |
| US-5,580,989 |
Process for the preparation of N-4-[(substituted phenyl)alkylheterocyclic]-
N A process for preparing a compound of the structure I ##STR1## where A is oxygen and sulfur and R.sup.1 is selected from the group consisting of hydrogen,... |
| US-5,580,988 |
Substituted azetidines and processes of using them New N-nitro, 3 substituted azetidine compounds are disclosed and these are sed in processes to prepare TNAZ. |
| US-5,580,987 |
Process for preparing 1-aminoacetamidopyrroles There is disclosed a process for the preparation of 1-aminoacetamidopyrroles and 1-amino-2-(substituted)-pyrroles and related compounds of the formula ... |
| US-5,580,986 |
Substituted pyrazole derivatives New substituted pyrazole derivatives of general formula I are described ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 have the ... |
| US-5,580,985 |
Substituted pyrazoles for the treatment of inflammation A class of pyrazolyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by... |
| US-5,580,984 |
Retroviral protease inhibiting compounds A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed. |
| US-5,580,983 |
Process for the preparation of N-acylated 2-chloro-5-aminomethylpyridines 2-Chloro-5-(N-acyl-aminomethyl)pyridines can be prepared by hydrogenation of 2-chloro-5-cyanopyridine with hydrogen in an acylating agent using a hydrogenation... |
| US-5,580,982 |
Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds This application relates to compounds of the formula ##STR1## wherein R.sup.1, X, Y and n are as defined in the specification; and pharmaceutically... |
| US-5,580,981 |
Azahydroxybenzotriazoles and derivatives thereof for peptide coupling
reactions This invention relates to a process for forming an amide or an ester from a reaction between an amine or an alcohol, respectively and an acylating derivative of... |
| US-5,580,980 |
N-aminopyridone dyes Pyridone dyes useful for thermal transfer have the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, Y, X and Z are defined in the specification. |
| US-5,580,979 |
Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions The present invention makes available novel compounds represented by the general formula ##STR1## wherein Y represents a phosphate analog. Which compounds... |
| US-5,580,978 |
Process for the production of 7-ACA derivatives The invention provides an improved process for the production of 7-amino-3-alkoxymethlycephem-4-carboxyl acid derivatives. |
| US-5,580,977 |
Process for preparing loracarbef monohydrate The invention is directed to a crystalline anhydrate solvate of loracarbef, and also is directed to a process for preparing a crystalline monohydrate form of the... |
| US-5,580,976 |
Preparation of .beta.-lactam compounds, and intermediates therefor A process for preparing a .beta.-lactam compound of the formula (I): ##STR1## which comprises cyclization of an azetidinone derivative of the formula: ... |
| US-5,580,975 |
Agent for keeping cut flowers fresh An agent for keeping cut flowers fresh contains a polysaccharide gel, such as gellan gum, dispersed at a concentration of 0.05 wt. % to 1.50 wt. %, into water,... |
| US-5,580,974 |
Microfibrillated oxycellulose dispersions Microfibrillated oxycellulose suitable for use as a carrier in agricultural, cosmetic, and topical and transdermal drug products, and as a binder and... |
| US-5,580,973 |
Process for preparing optically active nucleosides from chiral
cyclobutanones A process is disclosed for the preparation of optically active purine nucleosides, particularly nucleosides of formulae 1 and 2, nucleoside analogs and optically... |
| US-5,580,972 |
Purine nucleoside modifications by palladium catalyzed methods This invention discloses an improved method for the preparation modified purine nucleosides at the 2-, 6-, or 8-position of the purine ring, using a palladium... |
| US-5,580,971 |
Fungal detection system based on rRNA probes The invention includes methods for the detection of a particular genus or species of fungus in a biological sample. Some of these methods make use of a solid... |
| US-5,580,970 |
Detection of HPV transcripts A method for detecting and/or quantitating specific DNA and/or RNA transcripts of human papillomavirus (HPV) is described. Nucleic acid probes specific for DNA... |
| US-5,580,969 |
Antisense oligonucleotides directed against human ICAM-I RNA The present invention provides a method for the treatment of septic shock and inflammatory complications of shock. A process for selectively inhibiting the... |
| US-5,580,968 |
DNA encoding phospholipase activating protein The invention provides methods for detecting elevated levels of phospholipase A.sub.2 activating protein in persons suspected of having rheumatoid arthritis to... |
| US-5,580,967 |
Optimized catalytic DNA-cleaving ribozymes The present invention discloses nucleic acid enzymes capable of cleaving nucleic acid molecules, including single-stranded DNA, in a site-specific manner under... |
| US-5,580,966 |
Process for the synthesis of polyol fatty acid polyesters The present invention pertains to a process for the production of polyol fatty acid polyesters by reacting a reactant mixture of polyol, a fatty acid lower alkyl... |
| US-5,580,965 |
Disazo dyestuffs Disazo dyestuffs have been found which, in the form of the free acid, correspond to the formula (I) ##STR1## represents H or an optionally substituted... |
| US-5,580,964 |
Cationic thiadiazole dyestuffs Cationic 1,3,4-thiadiazole dyestuffs of the formula ##STR1## in which the symbols used have the meaning given in the description, corresponding... |
| US-5,580,963 |
Single-chain hepatocyte growth factor variants The invention concerns hepatocyte growth factor (HGF) variants that are resistant to proteolytic cleavage by enzymes capable of in vivo conversion of HGF into... |
| US-5,580,962 |
Parenterally administrable drug having thrombolytic activity and
containing protein C A thrombolytic, parenterally administrable drug containing activated protein C is provided for. The drug is free of serum amyloid P, thrombin activity,... |
| US-5,580,961 |
Heterodimeric T lymphocyte receptor subunit Disclosed is a heterodimeric T lymphocyte receptor subunit. The subunit consists of variable, joining, constant, transmembrane, and cytoplasmic regions. The... |
| US-5,580,960 |
KS-laminin and methods of use KS-laminin and a KS-laminin-kalinin adduct are disclosed. The molecules of the invention are useful for promoting the adhesion of keratinocytes to a substrate. |
| US-5,580,959 |
Purification of zein from corn gluten meal This invention pertains to methods for extracting and purifying zein, zein bodies, glutelins or destarched corn gluten from corn gluten meal by efficiently... |
| US-5,580,958 |
Polypeptides encoding transcriptional activators and uses thereof The invention provides a purified polypeptide having substantially the same amino acid sequence and activity as the protein having the amino acid sequence of... |
| US-5,580,957 |
GnRH analogs Peptides which include unnatural amino acids and which either promote or inhibit the secretion of gonadotropins by the pituitary gland and inhibit the release of... |
| US-5,580,956 |
Phospholipase C-inhibiting peptides The present invention relates to a peptide which has phospholipase C-inhibiting activity and which has the amino acid sequence defined in Sequence Listing by SEQ... |
| US-5,580,955 |
Fragments of neurofibromin (NF1) and method to reverse activated ras
induced malignant transformation in... This invention provides for a mechanism to reverse the activated Ras induced malignant transformation of mammalian cells by use of certain peptides.... |
| US-5,580,954 |
Anti-obesity proteins The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to... |
| US-5,580,953 |
Amylin antagonist peptides and uses therefor Compounds which inhibit amylin activity are provided. These compounds may be used in the treatment of conditions where it is of benefit to reduce amylin... |
| US-5,580,952 |
Process for producing an extraction chromatography resin A process for producing a resin for the chromatographic extraction of metal ions is provided, the process involving: treating an acidic bidentate organic phosphonate... |
| US-5,580,951 |
Method for preparing aromatic bischloroformate compositions and
polycarbonates Bischloroformate oligomer compositions are prepared by passing phosgene into a heterogeneous aqueous-organic mixture containing at least one dihydroxyaromatic... |
| US-5,580,950 |
Negative birefringent rigid rod polymer films A class of soluble polymers having a rigid rod backbone, which when used to cast films, undergo a self-orientation process whereby the polymer backbone becomes... |
| US-5,580,949 |
Metal ion reduction in novolak resins and photoresists The present invention provides methods for producing water insoluble, aqueous alkali soluble novolak resins having a very low level of metal ions, utilizing... |
Copyright 2008−2012 Patents.com
